Latest News

Experts debate low-carb diets for people with diabetes


 

AT ADA 2023

Rebuttals: Overall diet, patient preference matter

During the rebuttals, Dr. Kirkpatrick pointed out that large LDL particles are also atherogenic. In addition, she noted that the studies that showed that saturated fat isn’t associated with cardiovascular disease didn’t consider the macronutrients that replaced the saturated fat.

“It really is about increasing consumption of foods that we know are associated with cardiovascular benefit, including plant-based foods that are high quality and not refined carbohydrates ... and healthy protein sources. ... Hopefully we can step away from just looking at macronutrients and look at the total amount of food that people are choosing to eat.”

Importantly, Dr. Kirkpatrick said, patients need to be asked about their current dietary patterns and preferences. “Interventions should be patient centered and sensitive to cultural differences. Personalized lifestyle interventions increase the likelihood of success.”

Dr. Griauzde pointed out that newer antiobesity drugs can be added to any diet to decrease appetite and enhance adherence.

Dr. Griauzde also observed, “We can label a very-low-carbohydrate diet ‘extreme,’ but maybe, from the patient’s perspective, it’s extreme to take 200 units of insulin a day. If you can give them the opportunity to discontinue use of the insulin by following a very-low-carbohydrate dietary pattern, that is the opportunity that our patients deserve to have.”

But overall, she agreed with Dr. Kirkpatrick about individualizing any dietary approach: “We will never know from any of the trials that have been done or that will be done in the future what diet is best for an individual patient. ... Our job is to help our patients find the dietary approach that works best for them.”

Dr. Kirkpatrick is a clinical scientist with Midwest Biomedical Research, which has received funding from various food and pharmaceutical companies. She has not received any direct funding. Dr. Yancy is a consultant for The Simply Good Foods Co. Dr. Griauzde has disclosed no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Human frailty is a cash cow
MDedge Endocrinology
Continuous glucose monitors for pregnant patients?
MDedge Endocrinology
Apple cider vinegar, fenugreek best herbal remedies for T2D: Review
MDedge Endocrinology
Liraglutide fixes learning limit tied to insulin resistance
MDedge Endocrinology
ESC backs SGLT2 inhibitor plus GLP-1 in diabetes with high CVD risk
MDedge Endocrinology
Both too much and not enough sleep raises T2D risk
MDedge Endocrinology
Even an hour’s walk a week lowers risk in type 2 diabetes
MDedge Endocrinology
Medicare announces 10 drugs targeted for price cuts in 2026
MDedge Endocrinology
FDA clears new capabilities for diabetes app BlueStar
MDedge Endocrinology
Diabetes drug class appears to reduce recurrent gout flares
MDedge Endocrinology